{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T19:45:59Z","timestamp":1790538359289,"version":"4.1.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","award":["58\/27\/2007-BMS"],"award-info":[{"award-number":["58\/27\/2007-BMS"]}],"id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","award":["58\/36\/2013-BMS"],"award-info":[{"award-number":["58\/36\/2013-BMS"]}],"id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Divers"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1007\/s11030-019-09919-6","type":"journal-article","created":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T20:26:35Z","timestamp":1549052795000},"page":"927-951","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Structure-aided drug development of potential neuraminidase inhibitors against pandemic H1N1 exploring alternate binding mechanism"],"prefix":"10.1007","volume":"23","author":[{"given":"Khushboo D.","family":"Malbari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anand S.","family":"Chintakrindi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lata R.","family":"Ganji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Devanshi J.","family":"Gohil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sweta T.","family":"Kothari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mamata V.","family":"Joshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5640-8820","authenticated-orcid":false,"given":"Meena A.","family":"Kanyalkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,2,1]]},"reference":[{"key":"9919_CR1","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1128\/jvi.69.2.1099-1106.1995","volume":"69","author":"C Liu","year":"1995","unstructured":"Liu C, Eichelberger MC, Compans RW, Air GM (1995) Influenza type A virus neuraminidase does not play a role in viral entry, replication, assembly, or budding. J Virol 69:1099\u20131106","journal-title":"J Virol"},{"key":"9919_CR2","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/0042-6822(74)90276-1","volume":"61","author":"P Palese","year":"1974","unstructured":"Palese P, Tobita K, Ueda M, Compans RW (1974) Characterization of temperature sensitive influenza virus mutants defective in neuraminidase. Virology 61:397\u2013410","journal-title":"Virology"},{"key":"9919_CR3","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1038\/nrd2175","volume":"5","author":"E De Clercq","year":"2006","unstructured":"De Clercq E (2006) Antiviral agents active against influenza A viruses. Nat Rev Drug Discov 5:1015\u20131025. https:\/\/doi.org\/10.1038\/nrd2175","journal-title":"Nat Rev Drug Discov"},{"key":"9919_CR4","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1093\/infdis\/jiq012","volume":"203","author":"FG Hayden","year":"2011","unstructured":"Hayden FG, de Jong MD (2011) Emerging influenza antiviral resistance threats. J Infect Dis 203:6\u201310","journal-title":"J Infect Dis"},{"key":"9919_CR5","doi-asserted-by":"crossref","unstructured":"Trebbien R, Pedersen SS, Vorborg K et al (2017) Development of oseltamivir and zanamivir resistance in influenza A(H1N1)pdm09 virus, Denmark, 2014. Eurosurveillance 22","DOI":"10.2807\/1560-7917.ES.2017.22.3.30445"},{"key":"9919_CR6","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1056\/NEJM200003023420914","volume":"342","author":"JC Williamson","year":"2000","unstructured":"Williamson JC, Pegram PS (2000) Respiratory distress associated with zanamivir. N Engl J Med 342:661\u2013662","journal-title":"N Engl J Med"},{"key":"9919_CR7","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1177\/095632029901000401","volume":"10","author":"CU Kim","year":"1999","unstructured":"Kim CU, Chen X, Mendel DB (1999) Neuraminidase inhibitors as anti-influenza virus agents. Antivir Chem Chemother 10:141\u2013154. https:\/\/doi.org\/10.1177\/095632029901000401","journal-title":"Antivir Chem Chemother"},{"key":"9919_CR8","doi-asserted-by":"publisher","first-page":"1636","DOI":"10.1021\/np1002753","volume":"73","author":"T-T Dao","year":"2010","unstructured":"Dao T-T, Tung B-T, Nguyen P-H et al (2010) C-Methylated flavonoids from Cleistocalyx operculatus and their inhibitory effects on novel influenza A (H1N1) neuraminidase. J Nat Prod 73:1636\u20131642. https:\/\/doi.org\/10.1021\/np1002753","journal-title":"J Nat Prod"},{"key":"9919_CR9","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/j.bmcl.2010.11.016","volume":"21","author":"TT Dao","year":"2011","unstructured":"Dao TT, Nguyen PH, Lee HS et al (2011) Chalcones as novel influenza A (H1N1) neuraminidase inhibitors from Glycyrrhiza inflata. Bioorg Med Chem Lett 21:294\u2013298. https:\/\/doi.org\/10.1016\/j.bmcl.2010.11.016","journal-title":"Bioorg Med Chem Lett"},{"key":"9919_CR10","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1016\/j.bmcl.2009.12.106","volume":"20","author":"YB Ryu","year":"2010","unstructured":"Ryu YB, Kim JH, Park S-J et al (2010) Inhibition of neuraminidase activity by polyphenol compounds isolated from the roots of Glycyrrhiza uralensis. Bioorg Med Chem Lett 20:971\u2013974. https:\/\/doi.org\/10.1016\/j.bmcl.2009.12.106","journal-title":"Bioorg Med Chem Lett"},{"issue":"2","key":"9919_CR11","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/j.foodchem.2010.06.049","volume":"124","author":"TNA Nguyen","year":"2010","unstructured":"Nguyen TNA, Dao TT, Tung BT, Choi H, Kim E, Park J et al (2010) Influenza A (H1N1) neuraminidase inhibitors from Vitis amurensis. Food Chem 124(2):437\u2013443. https:\/\/doi.org\/10.1016\/j.foodchem.2010.06.049","journal-title":"Food Chem"},{"key":"9919_CR12","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1007\/s00044-017-2124-2","volume":"27","author":"AS Chintakrindi","year":"2018","unstructured":"Chintakrindi AS, Gohil DJ, Kothari ST et al (2018) Design, synthesis and evaluation of chalcones as H1N1 Neuraminidase inhibitors. Med Chem Res 27:1013\u20131025. https:\/\/doi.org\/10.1007\/s00044-017-2124-2","journal-title":"Med Chem Res"},{"key":"9919_CR13","doi-asserted-by":"publisher","first-page":"179","DOI":"10.4149\/av_2018_209","volume":"62","author":"K Malbari","year":"2018","unstructured":"Malbari K, Gonsalves H, Chintakrindi A et al (2018) In search of effective H1N1 neuraminidase inhibitor by molecular docking, antiviral evaluation and membrane interaction studies using NMR. Acta Virol 62:179\u2013190. https:\/\/doi.org\/10.4149\/av_2018_209","journal-title":"Acta Virol"},{"key":"9919_CR14","first-page":"79","volume":"8","author":"P Suruse","year":"2016","unstructured":"Suruse P, Malbari K, Chintakrindi A, Gohil D, Srivastava S, Kothari S, Chowdhary A, Meena K (2016) Virucidal activity of newly synthesized chalcone derivatives against H1N1 virus supported by molecular docking and membrane interaction studies. J Antivir Antiretrovir 8:79\u201389","journal-title":"J Antivir Antiretrovir"},{"key":"9919_CR15","doi-asserted-by":"publisher","first-page":"388","DOI":"10.4172\/2161-0444.1000270","volume":"5","author":"B Zhou","year":"2015","unstructured":"Zhou B, Xing C (2015) Diverse molecular targets for chalcones with varied bioactivities. Med Chem (Los Angeles) 5:388\u2013404","journal-title":"Med Chem (Los Angeles)"},{"key":"9919_CR16","doi-asserted-by":"publisher","first-page":"8073","DOI":"10.1016\/j.bmc.2009.10.002","volume":"17","author":"A Detsi","year":"2009","unstructured":"Detsi A, Majdalani M, Kontogiorgis CA et al (2009) Natural and synthetic 2\u2032-hydroxy-chalcones and aurones: synthesis, characterization and evaluation of the antioxidant and soybean lipoxygenase inhibitory activity. Bioorg Med Chem 17:8073\u20138085. https:\/\/doi.org\/10.1016\/j.bmc.2009.10.002","journal-title":"Bioorg Med Chem"},{"key":"9919_CR17","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1111\/cbdd.12458","volume":"85","author":"N Morales-Camilo","year":"2015","unstructured":"Morales-Camilo N, Salas CO, Sanhueza C et al (2015) Synthesis, biological evaluation, and molecular simulation of chalcones and aurones as selective MAO-B inhibitors. Chem Biol Drug Des 85:685\u2013695. https:\/\/doi.org\/10.1111\/cbdd.12458","journal-title":"Chem Biol Drug Des"},{"key":"9919_CR18","doi-asserted-by":"publisher","first-page":"e158","DOI":"10.1016\/j.rvsc.2010.11.010","volume":"91","author":"HD Gravina","year":"2011","unstructured":"Gravina HD, Tafuri NF, Silva J\u00fanior A et al (2011) In vitro assessment of the antiviral potential of trans-cinnamic acid, quercetin and morin against equid herpesvirus 1. Res Vet Sci 91:e158\u2013e162. https:\/\/doi.org\/10.1016\/j.rvsc.2010.11.010","journal-title":"Res Vet Sci"},{"key":"9919_CR19","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1007\/BF00771641","volume":"22","author":"AP Stankyavichyus","year":"1988","unstructured":"Stankyavichyus AP, Stankyavichene LMM, Sapragonene MS et al (1988) Synthesis and antiviral activity of cinnamic acid derivatives. Pharm Chem J 22:896\u2013900. https:\/\/doi.org\/10.1007\/BF00771641","journal-title":"Pharm Chem J"},{"key":"9919_CR20","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.antiviral.2017.07.018","volume":"145","author":"R Amano","year":"2017","unstructured":"Amano R, Yamashita A, Kasai H et al (2017) Cinnamic acid derivatives inhibit hepatitis C virus replication via the induction of oxidative stress. Antivir Res 145:123\u2013130. https:\/\/doi.org\/10.1016\/j.antiviral.2017.07.018","journal-title":"Antivir Res"},{"key":"9919_CR21","doi-asserted-by":"publisher","first-page":"2667","DOI":"10.1021\/jm800455g","volume":"52","author":"J An","year":"2009","unstructured":"An J, Lee DCW, Law AHY et al (2009) A novel small-molecule inhibitor of the avian influenza H5N1 virus determined through computational screening against the neuraminidase. J Med Chem 52:2667\u20132672. https:\/\/doi.org\/10.1021\/jm800455g","journal-title":"J Med Chem"},{"key":"9919_CR22","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/S0378-8741(99)00049-5","volume":"68","author":"AC Kudi","year":"1999","unstructured":"Kudi AC, Myint SH (1999) Antiviral activity of some Nigerian medicinal plant extracts. J Ethnopharmacol 68:289\u2013294","journal-title":"J Ethnopharmacol"},{"key":"9919_CR23","unstructured":"Discovery Studio, 3.1; Accelrys Inc. San Diego"},{"key":"9919_CR24","doi-asserted-by":"publisher","first-page":"2785","DOI":"10.1002\/jcc.21256","volume":"30","author":"GM Morris","year":"2009","unstructured":"Morris GM, Huey R, Lindstrom W et al (2009) AutoDock4 and AutoDockTools4: automated docking with selective receptor flexibility. J Comput Chem 30:2785\u20132791. https:\/\/doi.org\/10.1002\/jcc.21256","journal-title":"J Comput Chem"},{"key":"9919_CR25","doi-asserted-by":"publisher","first-page":"e1002249","DOI":"10.1371\/journal.ppat.1002249","volume":"7","author":"CJ Vavricka","year":"2011","unstructured":"Vavricka CJ, Li Q, Wu Y et al (2011) Structural and functional analysis of laninamivir and its octanoate prodrug reveals group specific mechanisms for influenza NA inhibition. PLoS Pathog 7:e1002249. https:\/\/doi.org\/10.1371\/journal.ppat.1002249","journal-title":"PLoS Pathog"},{"key":"9919_CR26","first-page":"831","volume":"12","author":"SMD Rizvi","year":"2013","unstructured":"Rizvi SMD, Shakil S, Haneef M (2013) A simple click by click protocol to perform docking: AutoDock 4.2 made easy for non-bioinformaticians. EXCLI J. 12:831\u2013857","journal-title":"EXCLI J."},{"key":"9919_CR27","unstructured":"Suite, Samll-Molecule Drug Discovery (2013) QikProp, version 3.3, User Manual, Schrodinger, LLC, New York, NY2013"},{"key":"9919_CR28","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/0022-1759(83)90303-4","volume":"65","author":"T Mosmann","year":"1983","unstructured":"Mosmann T (1983) Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 65:55\u201363","journal-title":"J Immunol Methods"},{"key":"9919_CR29","first-page":"111","volume-title":"Handbook of experimental pharmacology","author":"M von Itzstein","year":"2009","unstructured":"Itzstein M von, Thomson R (2009) Anti-influenza drugs: the development of sialidase inhibitors BT\u2014Antiviral strategies. In: Kr\u00e4usslich H-G, Bartenschlager R (eds) Handbook of experimental pharmacology, vol 189. Springer, Berlin, pp 111\u2013154"},{"key":"9919_CR30","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.2174\/138955712802761997","volume":"12","author":"A Chintakrindi","year":"2012","unstructured":"Chintakrindi A, D\u2019souza C, Kanyalkar M (2012) Rational development of neuraminidase inhibitor as novel anti-flu drug. Mini-Rev Med Chem 12:1273\u20131281","journal-title":"Mini-Rev Med Chem"},{"key":"9919_CR31","doi-asserted-by":"publisher","first-page":"1266","DOI":"10.1038\/nsmb.1909","volume":"17","author":"Q Li","year":"2010","unstructured":"Li Q, Qi J, Zhang W et al (2010) The 2009 pandemic H1N1 neuraminidase N1 lacks the 150-cavity in its active site. Nat Struct Mol Biol 17:1266","journal-title":"Nat Struct Mol Biol"},{"key":"9919_CR32","doi-asserted-by":"publisher","first-page":"5351","DOI":"10.1021\/bi00391a020","volume":"26","author":"MR Lentz","year":"1987","unstructured":"Lentz MR, Webster RG, Air GM (1987) Site-directed mutation of the active site of influenza neuraminidase and implications for the catalytic mechanism. Biochemistry 26:5351\u20135358. https:\/\/doi.org\/10.1021\/bi00391a020","journal-title":"Biochemistry"},{"key":"9919_CR33","doi-asserted-by":"publisher","first-page":"358","DOI":"10.2174\/156802611794480927","volume":"11","author":"MP Gleeson","year":"2011","unstructured":"Gleeson MP, Hersey A, Hannongbua S (2011) In-silico ADME models: a general assessment of their utility in drug discovery applications. Curr Top Med Chem 11:358\u2013381","journal-title":"Curr Top Med Chem"},{"key":"9919_CR34","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1021\/jm00390a002","volume":"30","author":"WJ Dunn","year":"1987","unstructured":"Dunn WJ, Koehler MG, Grigoras S (1987) The role of solvent-accessible surface area in determining partition coefficients. J Med Chem 30:1121\u20131126. https:\/\/doi.org\/10.1021\/jm00390a002","journal-title":"J Med Chem"},{"key":"9919_CR35","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/S0169-409X(96)00423-1","volume":"23","author":"CA Lipinski","year":"1997","unstructured":"Lipinski CA, Lombardo F, Dominy BW, Feeney PJ (1997) Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Deliv Rev 23:3\u201325. https:\/\/doi.org\/10.1016\/S0169-409X(96)00423-1","journal-title":"Adv Drug Deliv Rev"}],"container-title":["Molecular Diversity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11030-019-09919-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11030-019-09919-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11030-019-09919-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T05:14:52Z","timestamp":1744175692000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11030-019-09919-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,1]]},"references-count":35,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,11]]}},"alternative-id":["9919"],"URL":"https:\/\/doi.org\/10.1007\/s11030-019-09919-6","relation":{},"ISSN":["1381-1991","1573-501X"],"issn-type":[{"value":"1381-1991","type":"print"},{"value":"1573-501X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2,1]]},"assertion":[{"value":"22 October 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 January 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 February 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}